Hope in Every Breath: Navigating the Therapeutic Landscape of Cystic Fibrosis
- PMID: 37719614
- PMCID: PMC10504422
- DOI: 10.7759/cureus.43603
Hope in Every Breath: Navigating the Therapeutic Landscape of Cystic Fibrosis
Abstract
Cystic fibrosis (CF) has long posed a complex challenge to medical science. Still, the tides are turning with remarkable progress in prognosis and demographics, thanks to cutting-edge medical management and treatment breakthroughs. It affects multiple systems, necessitating a comprehensive approach to its management. This article thoroughly reviews the latest advancements in CF treatment across three key areas: respiratory care, infection prevention, and pharmacological management. In respiratory care, emphasis is placed on airway clearance therapies and nebulized saline, while infection prevention strategies encompass hand hygiene, respiratory etiquette, and environmental cleaning and disinfection. Pharmacological management explores pancreatic enzyme replacement therapy (PERT), antimicrobial treatments, cystic fibrosis transmembrane regulator (CFTR) modulators, and promising gene therapies. Patient education and support are highlighted as crucial components of effective CF management, while mental health assessments are emphasized due to CF patients' susceptibility to anxiety and depression. This review highlights the tremendous progress made in the management of CF. Integrating early detection, infection prevention, pharmacological interventions, gene therapy, and patient support is revolutionizing the care and quality of life for individuals with CF.
Keywords: cftr modulating therapy; chest physiotherapy; cystic fibrosis (cf); gene therapy; hand hygiene compliance; infection prevention and control; patient education; pulmonary screening; respiratory care.
Copyright © 2023, Sreenivasulu et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Cystic fibrosis: current concepts. López-Valdez JA, Aguilar-Alonso LA, Gándara-Quezada V, Ruiz-Rico GE, Ávila-Soledad JM, Reyes AA, Pedroza-Jiménez FD. https://doi.org/10.24875/BMHIM.20000372. Bol Med Hosp Infant Mex. 2021;78:584–596. - PubMed
-
- The changing epidemiology of cystic fibrosis: incidence, survival and impact of the CFTR gene discovery. Scotet V, L'Hostis C, Férec C. https://doi.org/10.3390/genes11060589. Genes. 2020;11:589. - PMC - PubMed
-
- Cystic fibrosis lung disease: an overview. Turcios NL. https://doi.org/10.4187/respcare.06697. Respir Care. 2020;65:233–251. - PubMed
-
- CFTR: cystic fibrosis and beyond. Mall MA, Hartl D. https://doi.org/10.1183/09031936.00228013. Eur Respir J. 2014;44:1042–1054. - PubMed
-
- Cystic fibrosis diagnosis and newborn screening. Rosenfeld M, Sontag MK, Ren CL. Pediatr Clin North Am. 2016;63:599–615. - PubMed
Publication types
LinkOut - more resources
Full Text Sources